secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001171843-24-001508
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase Q4/FY2023 revenue flat at $37.3M; net loss widens to $4.4M; secures $6M financing
--------------------------------------------------------------------------------

- Q4 revenue $8.0M (vs $8.3M YoY); full-year revenue $37.3M flat; net loss $4.4M ($0.09/sh) vs $2.6M in 2022.
- Solésence revenue grew 9% to $25.2M; Personal Care Ingredients fell 17% to $9.3M; Advanced Materials fell 9% to $2.8M.
- Closed $6M financing package in March 2024 to support working capital and growth.
- Litigation costs contributed $1.3M to operating loss; company expects lower costs and positive resolution ahead.
- Management expects $35M in shipped and open POs so far in 2024, with more orders expected in Q2-Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/0001171843-24-001508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184324001508/f8k_032024.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-001508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer